Status:
RECRUITING
Barts Revascularisation Registry
Lead Sponsor:
Queen Mary University of London
Conditions:
Myocardial Infarction
Stable Angina
Eligibility:
All Genders
16+ years
Brief Summary
Despite the year-on-year decrease, coronary artery disease (CAD) still remains one of the leading cause of mortality worldwide. With advances in technology and our understanding of cardiac disease, we...
Detailed Description
The collection of data to describe the nationwide practice of percutaneous coronary intervention (PCI) in the UK started with the inception of the British Cardiovascular Intervention Society (BCIS) in...
Eligibility Criteria
Inclusion
- Informed consent will not be sought for, as patients are automatically included onto a database that we will use for research purposes.
- No children will be included in this study.
- Vulnerable adults or those unable to give consent will be included in the study as well if they are referred to the Interventional Cardiology team.
- Both male and female patients ≥16 years of age will be included
- All patients will have had an angiogram at BHC.
- Any patient who has undergone revascularisation.
Exclusion
- • Patients \<16 years will not be included in this study.
Key Trial Info
Start Date :
August 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT05255705
Start Date
August 6 2021
End Date
March 1 2026
Last Update
July 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barts Health NHS Trust
London, United Kingdom